Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2009 Aug 4;10:356. doi: 10.1186/1471-2164-10-356

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright ©2009 Wang et al; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

mRNA profiling of SMF-treated hEBD cells. (A) The magnitude and number of genes that showed statistically significant changes in mRNA levels after SMF exposure compared to untreated control cells are given (four data points, representing genes with ≥ 5-fold changes in mRNA levels are not indicated in (A) but are shown in the expanded view of the 50 highest up- and down-regulated genes provided in (B); the "missing" genes are listed in Tables 2–4). Venn diagrams depicting the number of genes up- or down-regulated by ≥ 2-fold compared to cells continuously incubated under normal culture conditions are shown in Panels C and D, respectively. Note that the "1 day SMF" designation refers to the Group 2 treatment conditions described in the Methods section, (the greatest up- and down-regulated genes are listed in Table 2); "5 days SMF" refers to Group 3 cells (Table 3); and "w/1 day recovery" refers to Group 4 cells (Table 4); in all cases comparison is made to Group 1 control cells that were not exposed to SMF.